combination treatment

March 29, 2019

Combining DNA Damage Response Inhibitors with Immunotherapy Boosts SCLC Clearance, Mouse Study Shows

News

Combining anti-PD-L1 immunotherapies with agents that inhibit the DNA damage response (DDR) significantly enhances anti-tumor immunity and leads to rapid tumor disappearance in mouse models of small cell lung cancer (SCLC), a ... Read more

July 12, 2016July 12, 2016

Cancer Vaccine Used with PD-1 Blocker Seen to Improve Survival in Mice Models of Glioblastoma

News

Checkpoint inhibitors used in combination with a newly developed anti-tumor vaccine considerably prolonged survival in mice with established glioblastoma tumors in their brains, while neither treatment alone was of any benefit, ... Read more